Koyfin Home > Directory > Health Care > Apellis Pharmaceuticals Inc > Capital Expenditures

Apellis Pharmaceuticals Inc Capital Expenditures Chart (APLS)

Apellis Pharmaceuticals Inc annual/quarterly Capital Expenditures from 2014 to 2015.
  • Apellis Pharmaceuticals Inc Capital Expenditures for the quarter ending September 09, 2015 was $0m a 51.55% decrease of 0m year over year
  • Apellis Pharmaceuticals Inc Capital Expenditures for the last 12 months ending September 09, 2016 was $0m a 495.41% increase of 0m year over year
Other Cash Flow Metrics:
  • Apellis Pharmaceuticals Inc Cash Flow from Operations for the quarter ending December 12, 2018 was $-44m a 48.43% decrease of -22m year over year
  • Apellis Pharmaceuticals Inc Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-39m a 62.21% decrease of -24m year over year
View Chart On Koyfin

Quarterly APLS Capital Expenditures Data

09/2015$0m
06/2015$0m
03/2015$0m
09/2014$0m
06/2014$0m
03/2014$0m

Annual APLS Capital Expenditures Data

2014$0m